.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Optimizing Infection Control to Improve Outcomes of Allogeneic Stem Cell Transplant

EP. 1: Need for Infection Control in Patients Receiving High-Dose Therapy and Allogeneic Transplant

January 16th 2017

EP. 2: Azoles for Prophylaxis of Invasive Fungal Infections in Transplant Patients

January 16th 2017

EP. 3: Monitoring Azole Levels in Transplant Patients

January 16th 2017

EP. 4: Morbidity from CMV Infection in Transplant Patients

January 16th 2017

EP. 5: The Need for CMV Prophylaxis in the Transplant Setting

January 16th 2017

EP. 6: Letermovir for CMV Prophylaxis in Transplant Patients

January 16th 2017

EP. 7: Letermovir Phase III Trial

January 16th 2017